Ann: Net Tangible Asset Backing, page-3

With NTA of 34c and share price of just 23.5c then rather than a cap raise then winding up as suggested by another poster might be an reasonable suggestion? No rush or real issue as the NTA is clearly increasing and is likely to continue to do so.

Question by the market on the substantial change of direction from a grower, medical pill supplier and research to the current LIC was really a huge play for reasons not clearly understood or appreciated by the market. As a player we could have been a take over target. As a LIC I am not sure that's likely.